UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022119
Receipt number R000025392
Scientific Title Substrate Targeted Ablation of Persistent Atrial Fibrillation Trial
Date of disclosure of the study information 2016/07/14
Last modified on 2017/03/13 11:05:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Substrate Targeted Ablation of Persistent Atrial Fibrillation Trial

Acronym

START Trial

Scientific Title

Substrate Targeted Ablation of Persistent Atrial Fibrillation Trial

Scientific Title:Acronym

START Trial

Region

Japan


Condition

Condition

Persistent Atrial Fibrillation Patients

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Safety and efficacy of left atrial low voltage zone ablation.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Acute teremination of atrisl fibrillation, long term success, and complications after left atrial low voltage zone ablation.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking


Concealment

Central registration


Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Pulmonary vein antrum isolation (PVAI) and Left atrial low voltage zone (LVZ) ablation for patients with LVZ.

Interventions/Control_2

PVAI only for patients with LVZ.

Interventions/Control_3

PVAI for patients without LVZ.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Persistent atrial fibrillation patient who is undergoing initial atrial fibrillation ablation.

Key exclusion criteria

Patients with low cardiac function, left atrial thrombus, contraindication of anticoagulant therapy.

Target sample size

500


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tsuchiya Takeshi

Organization

EP Expert Doctors-Team Tsuchiya

Division name

Electrophysiology

Zip code


Address

Koto 3-14-28, Higashi-ku, Kumamoto

TEL

096-368-0403

Email

tsuchiya0210jupiter@yj8.so-net.ne.jp


Public contact

Name of contact person

1st name
Middle name
Last name Fukui Akira

Organization

EP Expert Doctors-Team Tsuchiya

Division name

Electrophysiology

Zip code


Address

Hirogi-machi 30-35-102, Higashi-ku, Kumamoto

TEL

090-2513-7156

Homepage URL


Email

akira18@oita-u.ac.jp


Sponsor or person

Institute

EP Expert Doctors-Team Tsuchiya

Institute

Department

Personal name



Funding Source

Organization

START Trial Meeting

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 07 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Date of protocol fixation

2015 Year 07 Month 24 Day

Date of IRB


Anticipated trial start date

2015 Year 09 Month 30 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 04 Month 28 Day

Last modified on

2017 Year 03 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025392


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name